FDA Drug Application (008303) for APRESOLINE by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number008303
Product Number001
FormTABLET;ORAL
Dosage25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAPRESOLINE
Active IngredientHYDRALAZINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient HYDRALAZINE HYDROCHLORIDE27


Back to FDA Applications sponsored by NOVARTIS